✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Gland Pharma Ltd.

GLAND

Market Cap
₹24,375 Cr.
P/E
34.60

Gland Pharma Ltd.

  • Gland Pharma
  • Caplin Point Lab
  • Gufic Biosciences
  • TJI Pharma - API & CRAMS
FAQs on Gland Pharma Ltd. Shareprice

Gland Pharma has given lower returns compared to its competitors.
Gland Pharma has grown at ~-13.64% over the last 4yrs while peers have grown at a median rate of 24.88%

Gland Pharma is not expensive.
Latest PE of Gland Pharma is 34.6, while 3 year average PE is 40.51.
Also latest EV/EBITDA of Gland Pharma is 17.06 while 3yr average is 26.37.

View FAQ's On Business
Growth Table
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences
Balance Sheet
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences
Cash Flow
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences
Quarterly Results
  • Gland Pharma Ltd.
  • Caplin Point Lab
  • Gufic Biosciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Gland Pharma Ltd. Financials

Balance sheet of Gland Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Gland Pharma is increasing.
Latest debt of Gland Pharma is -₹2,541.34 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹3,359.07 Crs.

No, profit is decreasing.
The profit of Gland Pharma is ₹704 Crs for TTM, ₹772 Crs for Mar 2024 and ₹781 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gland Pharma latest dividend payout ratio is 42.65% and 3yr average dividend payout ratio is 42.65%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech